Adjuvant Sunitinib Benefit after Oligometastasectomy for RCC? ASCO 2018

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Adjuvant Sunitinib Benefit after Oligometastasectomy for RCC? ASCO 2018

By Beacon Medical Interchange FEATURING Daniel Goldstein

167 views

November 2, 2018

Dr. Daniel Goldstein summarizes the findings of a randomized trial assessing the benefit of adjuvant ...
read more ↘ sunitinib following resection of oligometastatic disease in patients with renal cell carcinoma (RCC).
↖ read less

0 Comments

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary